<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365922">
  <stage>Registered</stage>
  <submitdate>24/06/2014</submitdate>
  <approvaldate>17/07/2014</approvaldate>
  <actrnumber>ACTRN12614000758606</actrnumber>
  <trial_identification>
    <studytitle>Effects of Sevoflurane and Desflurane on otoacoustic emissions (OAE) in healthy adult patients with normal hearing tests undergoing septoplasty and turbinoplasty surgery</studytitle>
    <scientifictitle>Effects of Sevoflurane and Desflurane on otoacoustic emissions (OAE) in healthy adult patients with normal hearing tests undergoing septoplasty and turbinoplasty surgery</scientifictitle>
    <utrn>U1111-1158-3595</utrn>
    <trialacronym />
    <secondaryid>29112011</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Otoacoustic emissions in  healthy adult patients before, during and following anaesthesia  with normal hearing tests</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Ear</conditioncode1>
      <conditioncode2>Normal ear development and function</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Arm 1: sevoflurane 2% by inhalation from induction until the end of the operation
Arm 2: desflurane 5% by inhalation from induction until the end of the operation
</interventions>
    <comparator>control measurement - before the start of inhalation agents while the patient is awake </comparator>
    <control>Active</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>overall transient evoked otoacoustic emissions (TEOAEs) measured  by Madsen Capella-otoacoustic emissions testing OAE system module version 2.12 software (Denmark)
</outcome>
      <timepoint>3dB difference at 5min after induction, at the end of surgery under anesthesia,1 hour after surgery in the ward from preinduction. Comparison between all time points were also evaluated.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome> distortion product otoacoustic emissions (DPOAEs) at  1kH, 1,5kH, 2kH, 3kH, 4kH, 6kH, 8kH Measurement performed by Madsen Capella-otoacoustic emissions testing OAE system module version 2.12 software (Denmark)</outcome>
      <timepoint>3dB t 5min after induction, at the end of surgery under anesthesia,1 hour after surgery in the ward from preinduction. Comparison between all time points were also evaluated.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>nil</outcome>
      <timepoint>nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Healthy patients with normal hearing tests who underwent septoplasty and turbinoplasty surgery
 </inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>50</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1.abnormal hearing test
2. TEAOE levels less than 3 dB SPL ( decibel -Sound pressure level )  or DPOAE levels less than 6 dBSPL in the preoperative measurements</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>central randomisation by phone/fax/computer</concealment>
    <sequence>Simple randomisation using a randomisation table created by computer software (i.e. computerised sequence generation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Pharmacokinetics / pharmacodynamics</endpoint>
    <statisticalmethods>Three dB Change in TEOAE's and DpOAE's considered relevant. Preinduction measurements at all variables varied from 10-19dB. The minimum changes of these parameters were 15%. At confidence level of 95% and confidence interval 15 % sample size of measurements calculated 22 patients each ear (44 ears) being measured. 
One-factor, repeated measures ANOVA
Linear regressions
Unpaired t- test  with repeated measures on the time factor</statisticalmethods>
    <masking1>False</masking1>
    <masking2>False</masking2>
    <masking3>True</masking3>
    <masking4>False</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>30/11/2011</anticipatedstartdate>
    <actualstartdate>20/06/2012</actualstartdate>
    <anticipatedenddate>29/03/2013</anticipatedenddate>
    <actualenddate>28/02/2013</actualenddate>
    <samplesize>22</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Gurcan Gungor</primarysponsorname>
    <primarysponsoraddress>Istanbul University Cerrahpasa Medical Faculty Dept of Anesthesiology and Reanimation
Fatih- ISTANBUL 34303 TURKEY</primarysponsoraddress>
    <primarysponsorcountry>Turkey</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>nil</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To determine the influence of the new short acting inhalation agents;desflurane and sevoflurane which are widely used in general anaesthesia on  otoacoustic emissions (OAEs) in humans. Otoacoustic emissions measured under desflurane and sevoflurane
anaesthesia. Both agents effect the systemic blood pressures and OAEs. Desflurane and sevoflurane effect OAE measurements by several mechanisms</summary>
    <trialwebsite />
    <publication>1. Presentation in National ENT Congress: 2013[SS-322] 
Eriskinlerde Genel Anestezi Sirasinda TEOAE ve DPOAE Degisiklikleri.G Gungor, O Gedik, A Atas, Rovnat Babazade, M Yilmaz, Pervin Sutas Bozkurt
2. Publication: 

Gurcan Gungor; Pervin Bozkurt-Sutas ; Ozge Gedik ; Ahmet Atas,; Rovnat Babazade; Mehmet Yilmaz. Effects of sevoflurane and desflurane on otoacoustic emissions in humans",Journal: European Archives of Oto-Rhino-Laryngology DOI: 10.1007/s00405-014-3124-1 - Mon, 09 Jun 2014 
</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Istanbul University Cerrahpas Medical Faculty Clinical Research Ethic Committee</ethicname>
      <ethicaddress>Istanbul University Cerrahpas Medical Faculty Clinical Research Ethic Committee
Cerrahpasa Deanery Building
Fatih- Istanbul 34303 TURKEY</ethicaddress>
      <ethicapprovaldate>29/11/2011</ethicapprovaldate>
      <hrec>43441</hrec>
      <ethicsubmitdate>17/11/2011</ethicsubmitdate>
      <ethiccountry>Turkey</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment>
    <filepath>http://www.anzctr.org.au/AnzctrAttachments/365922-OAE etik resmi.docx</filepath>
    <filepath>http://www.anzctr.org.au/AnzctrAttachments/365922-RSS Feed.docx</filepath>
  </attachment>
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Gurcan Gungor</name>
      <address>Istanbul University Cerrahpasa Medical Faculty, Dept of Anaesthesiology Fatih- Istanbul 34303 TURKEY
</address>
      <phone>+905326424355</phone>
      <fax>+902125733314</fax>
      <email>gugungor@yahoo.com;gugungor@hotmail.com</email>
      <country>Turkey</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Gurcan Gungor</name>
      <address>Istanbul University Cerrahpasa Medical Faculty, Dept of Anaesthesiology
Fatih- Istanbul 34303 TURKEY
</address>
      <phone>+905326424355</phone>
      <fax>+902125733314</fax>
      <email>gugungor@yahoo.com;gugungor@hotmail.com</email>
      <country>Turkey</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Gurcan Gungor</name>
      <address>Istanbul University Cerrahpasa Medical Faculty, Dept of Anaesthesiology
Fatih- Istanbul 34303 TURKEY
</address>
      <phone>+905326424355</phone>
      <fax>+902125733314</fax>
      <email>gugungor@yahoo.com;gugungor@hotmail.com</email>
      <country>Turkey</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Gurcan Gungor</name>
      <address>Istanbul University Cerrahpasa Medical Faculty, Dept of Anaesthesiology</address>
      <phone>+905326424355</phone>
      <fax>+902125733314</fax>
      <email>gugungor@yahoo.com;gugungor@hotmail.com</email>
      <country>Turkey</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>